Sonic Healthcare has lifted its full-year profit 11.2 per cent to $467.2 million due to the international pathology and radiology services group recording strong revenue growth in Europe.
Revenue was up 8.2 per cent to $5.5 billion, while its revenue in Europe was up 9.5 per cent to more than $2 billion.
Sonic will pay a final dividend of 49 cents, franked at 30 per cent and the group has forecast underlying earnings growth of three to five per cent for 2018/19, down from eight per cent.
The pathology and radiology giant had strong growth in most of its overseas markets, particularly Germany where revenue lifted 12 per cent.
Sonic shares were down 39 cents, or 1.5 per cent, to $26.39 at 1053 AEST.
GROWTH IN EUROPE AND US LIFTS SONIC’S PROFIT
* Full year net profit up 11.2 pct to $467.2m
* Revenue up 8.2 pct to $5.5b
* Final dividend up 3 cents to 49 cents, fully franked